{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T12:50:04Z","timestamp":1776948604090,"version":"3.51.4"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,8,2]],"date-time":"2015-08-02T00:00:00Z","timestamp":1438473600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1007\/s00259-015-3146-y","type":"journal-article","created":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T06:38:45Z","timestamp":1438411125000},"page":"184-192","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":68,"title":["Utility of the combination of DAT SPECT and MIBG myocardial scintigraphy in differentiating dementia with Lewy bodies from Alzheimer\u2019s disease"],"prefix":"10.1007","volume":"43","author":[{"given":"Soichiro","family":"Shimizu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Hirao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidekazu","family":"Kanetaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nayuta","family":"Namioka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirokuni","family":"Hatanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Hirose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raita","family":"Fukasawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiko","family":"Umahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirohumi","family":"Sakurai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruo","family":"Hanyu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,8,2]]},"reference":[{"key":"3146_CR1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S1474-4422(03)00619-7","volume":"3","author":"I McKeith","year":"2004","unstructured":"McKeith I, Mintzer J, Aarsland D, Burn D, Chiu H, Cohen-Mansfield J, et al. Dementia with Lewy bodies. Lancet Neurol 2004;3:19\u201328.","journal-title":"Lancet Neurol"},{"key":"3146_CR2","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1212\/WNL.47.5.1113","volume":"47","author":"IG McKeith","year":"1996","unstructured":"McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996;47:1113\u201324.","journal-title":"Neurology"},{"key":"3146_CR3","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/mds.10459","volume":"18","author":"I Litvan","year":"2003","unstructured":"Litvan I, Bhatia KP, Burn DJ, Goetz CG, Lang AE, McKeith I, et al. Movement Disorders Society Scientific Issues Committee report: SIC Task Force appraisal of clinical diagnostic criteria for Parkinsonian disorders. Mov Disord 2003;18:467\u201386. doi: 10.1002\/mds.10459 .","journal-title":"Mov Disord"},{"key":"3146_CR4","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","volume":"65","author":"IG McKeith","year":"2005","unstructured":"McKeith IG, Dickson DW, Lowe J, Emre M, O\u2019Brien JT, Feldman H, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 2005;65:1863\u201372. doi: 10.1212\/01.wnl.0000187889.17253.b1 .","journal-title":"Neurology"},{"key":"3146_CR5","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/1531-8257(200005)15:3<503::AID-MDS1013>3.0.CO;2-V","volume":"15","author":"TS Benamer","year":"2000","unstructured":"Benamer TS, Patterson J, Grosset DG, Booij J, de Bruin K, van Royen E, et al. Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study group. Mov Disord 2000;15:503\u201310.","journal-title":"Mov Disord"},{"key":"3146_CR6","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s002590000460","volume":"28","author":"J Booij","year":"2001","unstructured":"Booij J, Speelman JD, Horstink MW, Wolters EC. The clinical benefit of imaging striatal dopamine transporters with [123I]FP-CIT SPET in differentiating patients with presynaptic parkinsonism from those with other forms of parkinsonism. Eur J Nucl Med 2001;28:266\u201372.","journal-title":"Eur J Nucl Med"},{"key":"3146_CR7","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1136\/jnnp.73.2.134","volume":"73","author":"Z Walker","year":"2002","unstructured":"Walker Z, Costa DC, Walker RW, Shaw K, Gacinovic S, Stevens T, et al. Differentiation of dementia with Lewy bodies from Alzheimer\u2019s disease using a dopaminergic presynaptic ligand. J Neurol Neurosurg Psychiatry 2002;73:134\u201340.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3146_CR8","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S1474-4422(07)70057-1","volume":"6","author":"I McKeith","year":"2007","unstructured":"McKeith I, O\u2019Brien J, Walker Z, Tatsch K, Booij J, Darcourt J, et al. Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study. Lancet Neurol 2007;6:305\u201313. doi: 10.1016\/S1474-4422(07)70057-1 .","journal-title":"Lancet Neurol"},{"key":"3146_CR9","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1001\/archneur.61.6.919","volume":"61","author":"JT O\u2019Brien","year":"2004","unstructured":"O\u2019Brien JT, Colloby S, Fenwick J, Williams ED, Firbank M, Burn D, et al. Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies. Arch Neurol 2004;61:919\u201325. doi: 10.1001\/archneur.61.6.919 .","journal-title":"Arch Neurol"},{"key":"3146_CR10","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1136\/jnnp.2006.110122","volume":"78","author":"Z Walker","year":"2007","unstructured":"Walker Z, Jaros E, Walker RW, Lee L, Costa DC, Livingston G, et al. Dementia with Lewy bodies: a comparison of clinical diagnosis, FP-CIT single photon emission computed tomography imaging and autopsy. J Neurol Neurosurg Psychiatry 2007;78:1176\u201381. doi: 10.1136\/jnnp.2006.110122 .","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3146_CR11","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1192\/bjp.bp.108.052050","volume":"194","author":"JT O\u2019Brien","year":"2009","unstructured":"O\u2019Brien JT, McKeith IG, Walker Z, Tatsch K, Booij J, Darcourt J, et al. Diagnostic accuracy of 123I-FP-CIT SPECT in possible dementia with Lewy bodies. Br J Psychiatry 2009;194:34\u20139. doi: 10.1192\/bjp.bp.108.052050 .","journal-title":"Br J Psychiatry"},{"key":"3146_CR12","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1212\/01.WNL.0000123248.39847.1D","volume":"62","author":"Z Walker","year":"2004","unstructured":"Walker Z, Costa DC, Walker RW, Lee L, Livingston G, Jaros E, et al. Striatal dopamine transporter in dementia with Lewy bodies and Parkinson disease: a comparison. Neurology 2004;62:1568\u201372.","journal-title":"Neurology"},{"key":"3146_CR13","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1136\/jnnp-2012-302577","volume":"83","author":"S Morgan","year":"2012","unstructured":"Morgan S, Kemp P, Booij J, Costa DC, Padayachee S, Lee L, et al. Differentiation of frontotemporal dementia from dementia with Lewy bodies using FP-CIT SPECT. J Neurol Neurosurg Psychiatry 2012;83:1063\u201370. doi: 10.1136\/jnnp-2012-302577 .","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3146_CR14","first-page":"476","volume":"55","author":"V Camacho","year":"2011","unstructured":"Camacho V, Marqui\u00e9 M, Lle\u00f3 A, Alv\u00e9s L, Artigas C, Flotats A, et al. Cardiac sympathetic impairment parallels nigrostriatal degeneration in probable dementia with Lewy bodies. Q J Nucl Med Mol Imaging 2011;55:476\u201383.","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"3146_CR15","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1552-6569.2012.00774.x","volume":"24","author":"G Treglia","year":"2014","unstructured":"Treglia G, Cason E, Cortelli P, Gabellini A, Liguori R, Bagnato A, et al. Iodine-123 metaiodobenzylguanidine scintigraphy and iodine-123 ioflupane single photon emission computed tomography in Lewy body diseases: complementary or alternative techniques? J Neuroimaging 2014;24:149\u201354. doi: 10.1111\/j.1552-6569.2012.00774.x .","journal-title":"J Neuroimaging"},{"key":"3146_CR16","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1097\/RLU.0000000000000554","volume":"40","author":"TS Spehl","year":"2015","unstructured":"Spehl TS, Frings L, Hellwig S, Weiller C, H\u00fcll M, Meyer PT, et al. Role of semiquantitative assessment of regional binding potential in 123I-FP-CIT SPECT for the differentiation of frontotemporal dementia, dementia with Lewy bodies, and Alzheimer\u2019s dementia. Clin Nucl Med 2015;40:e27\u201333. doi: 10.1097\/RLU.0000000000000554 .","journal-title":"Clin Nucl Med"},{"key":"3146_CR17","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1136\/jnnp.71.5.583","volume":"71","author":"M Yoshita","year":"2001","unstructured":"Yoshita M, Taki J, Yamada M. A clinical role for [(123)I]MIBG myocardial scintigraphy in the distinction between dementia of the Alzheimer\u2019s-type and dementia with Lewy bodies. J Neurol Neurosurg Psychiatry 2001;71:583\u20138.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3146_CR18","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1136\/jnnp.70.6.781","volume":"70","author":"H Watanabe","year":"2001","unstructured":"Watanabe H, Ieda T, Katayama T, Takeda A, Aiba I, Doyu M, et al. Cardiac (123)I-meta-iodobenzylguanidine (MIBG) uptake in dementia with Lewy bodies: comparison with Alzheimer\u2019s disease. J Neurol Neurosurg Psychiatry 2001;70:781\u20133.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3146_CR19","doi-asserted-by":"crossref","first-page":"686","DOI":"10.2169\/internalmedicine.42.686","volume":"42","author":"T Oide","year":"2003","unstructured":"Oide T, Tokuda T, Momose M, Oguchi K, Nakamura A, Ohara S, et al. Usefulness of [123I]metaiodobenzylguanidine ([123I]MIBG) myocardial scintigraphy in differentiating between Alzheimer\u2019s disease and dementia with Lewy bodies. Intern Med 2003;42:686\u201390.","journal-title":"Intern Med"},{"key":"3146_CR20","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s00259-005-1921-x","volume":"33","author":"H Hanyu","year":"2006","unstructured":"Hanyu H, Shimizu S, Hirao K, Kanetaka H, Iwamoto T, Chikamori T, et al. Comparative value of brain perfusion SPECT and [(123)I]MIBG myocardial scintigraphy in distinguishing between dementia with Lewy bodies and Alzheimer\u2019s disease. Eur J Nucl Med Mol Imaging 2006;33:248\u201353. doi: 10.1007\/s00259-005-1921-x .","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3146_CR21","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jns.2007.03.016","volume":"260","author":"K Wada-Isoe","year":"2007","unstructured":"Wada-Isoe K, Kitayama M, Nakaso K, Nakashima K. Diagnostic markers for diagnosing dementia with Lewy bodies: CSF and MIBG cardiac scintigraphy study. J Neurol Sci 2007;260:33\u20137. doi: 10.1016\/j.jns.2007.03.016 .","journal-title":"J Neurol Sci"},{"key":"3146_CR22","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1007\/s00259-008-0828-8","volume":"35","author":"M Estorch","year":"2008","unstructured":"Estorch M, Camacho V, Paredes P, Rivera E, Rodr\u00edguez-Revuelto A, Flotats A, et al. Cardiac (123)I-metaiodobenzylguanidine imaging allows early identification of dementia with Lewy bodies during life. Eur J Nucl Med Mol Imaging 2008;35:1636\u201341. doi: 10.1007\/s00259-008-0828-8 .","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3146_CR23","doi-asserted-by":"crossref","unstructured":"Noguchi-Shinohara M, Tokuda T, Yoshita M, Kasai T, Ono K, Nakagawa M, et al. CSF alpha-synuclein levels in dementia with Lewy bodies and Alzheimer\u2019s disease. Brain Res 2009;1251:1\u20136. doi: 10.1016\/j.brainres.2008.11.055 .","DOI":"10.1016\/j.brainres.2008.11.055"},{"issue":"3","key":"3146_CR24","doi-asserted-by":"crossref","first-page":"e0120540","DOI":"10.1371\/journal.pone.0120540","volume":"10","author":"Y Mitsuhiro","year":"2015","unstructured":"Mitsuhiro Y, Miharu S, Heii A, Hiroyuki A, Eizo I, Takashi A, et al. Diagnostic accuracy of cardiac sympathetic imaging with 123I-MIBG myocardial scintigraphy in dementia with Lewy bodies: a multicenter study. PLoS One 2015;10(3):e0120540. doi: 10.1371\/journal.pone.0120540 .","journal-title":"PLoS One"},{"key":"3146_CR25","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1552-6569.2010.00532.x","volume":"22","author":"G Treglia","year":"2012","unstructured":"Treglia G, Cason E. Diagnostic performance of myocardial innervation imaging using MIBG scintigraphy in differential diagnosis between dementia with lewy bodies and other dementias: a systematic review and a meta-analysis. J Neuroimaging 2012;22:111\u20137. doi: 10.1111\/j.1552-6569.2010.00532.x .","journal-title":"J Neuroimaging"},{"key":"3146_CR26","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.parkreldis.2011.09.015","volume":"18","author":"ND Papathanasiou","year":"2012","unstructured":"Papathanasiou ND, Boutsiadis A, Dickson J, Bomanji JB. Diagnostic accuracy of 123I-FP-CIT (DaTSCAN) in dementia with Lewy bodies: a meta-analysis of published studies. Parkinsonism Relat Disord 2012;18:225\u20139. doi: 10.1016\/j.parkreldis.2011.09.015 .","journal-title":"Parkinsonism Relat Disord"},{"key":"3146_CR27","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/mds.20369","volume":"20","author":"J Spiegel","year":"2005","unstructured":"Spiegel J, M\u00f6llers MO, Jost WH, Fuss G, Samnick S, Dillmann U, et al. FP-CIT and MIBG scintigraphy in early Parkinson\u2019s disease. Mov Disord 2005;20:552\u201361. doi: 10.1002\/mds.20369 .","journal-title":"Mov Disord"},{"key":"3146_CR28","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1002\/mds.22771","volume":"24","author":"F Novellino","year":"2009","unstructured":"Novellino F, Arabia G, Bagnato A, Cascini GL, Salsone M, Nicoletti G, et al. Combined use of DAT-SPECT and cardiac MIBG scintigraphy in mixed tremors. Mov Disord 2009;24:2242\u20138. doi: 10.1002\/mds.22771 .","journal-title":"Mov Disord"},{"key":"3146_CR29","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.archger.2012.05.001","volume":"56","author":"JS Kim","year":"2013","unstructured":"Kim JS, Oh YS, Kim YI, Yang DW, Chung YA, You IR, et al. Combined use of 123I-metaiodobenzylguanidine (MIBG) scintigraphy and dopamine transporter (DAT) positron emission tomography (PET) predicts prognosis in drug-induced parkinsonism (DIP): a 2-year follow-up study. Arch Gerontol Geriatr 2013;56:124\u20138. doi: 10.1016\/j.archger.2012.05.001 .","journal-title":"Arch Gerontol Geriatr"},{"key":"3146_CR30","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1192\/bjp.140.6.566","volume":"140","author":"CP Hughes","year":"1982","unstructured":"Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL. A new clinical scale for the staging of dementia. Br J Psychiatry 1982;140:566\u201372.","journal-title":"Br J Psychiatry"},{"key":"3146_CR31","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR. \u201cMini-mental state\u201d. a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189\u201398.","journal-title":"J Psychiatr Res"},{"key":"3146_CR32","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","volume":"34","author":"G McKhann","year":"1984","unstructured":"McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s Disease. Neurology 1984;34:939\u201344.","journal-title":"Neurology"},{"key":"3146_CR33","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s00259-007-0621-0","volume":"35","author":"J Booij","year":"2008","unstructured":"Booij J, Kemp P. Dopamine transporter imaging with [(123)I]FP-CIT SPECT: potential effects of drugs. Eur J Nucl Med Mol Imaging 2008;35:424\u201338. doi: 10.1007\/s00259-007-0621-0 .","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3146_CR34","doi-asserted-by":"crossref","first-page":"154","DOI":"10.2967\/jnumed.111.100784","volume":"53","author":"DS Djang","year":"2012","unstructured":"Djang DS, Janssen MJ, Bohnen N, Booij J, Henderson TA, Herholz K, et al. SNM practice guideline for dopamine transporter imaging with 123I-ioflupane SPECT 1.0. J Nucl Med 2012;53:154\u201363. doi: 10.2967\/jnumed.111.100784 .","journal-title":"J Nucl Med"},{"key":"3146_CR35","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/00006231-199207000-00006","volume":"13","author":"KK Solanki","year":"1992","unstructured":"Solanki KK, Bomanji J, Moyes J, Mather SJ, Trainer PJ, Britton KE. A pharmacological guide to medicines which interfere with the biodistribution of radiolabelled meta-iodobenzylguanidine (MIBG). Nucl Med Commun 1992;13:513\u201321.","journal-title":"Nucl Med Commun"},{"key":"3146_CR36","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1001\/archneur.1975.00490510088009","volume":"32","author":"VC Hachinski","year":"1975","unstructured":"Hachinski VC, Iliff LD, Zilhka E, Du Boulay GH, McAllister VL, Marshall J, et al. Cerebral blood flow in dementia. Arch Neurol 1975;32:632\u20137.","journal-title":"Arch Neurol"},{"key":"3146_CR37","first-page":"165","volume":"39","author":"SE Daniel","year":"1993","unstructured":"Daniel SE, Lees AJ. Parkinson\u2019s Disease Society Brain Bank, London: overview and research. J Neural Transm Suppl 1993;39:165\u201372.","journal-title":"J Neural Transm Suppl"},{"key":"3146_CR38","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/BF02988527","volume":"17","author":"H Kobayashi","year":"2003","unstructured":"Kobayashi H, Momose M, Kanaya S, Kondo C, Kusakabe K, Mitsuhashi N. Scatter correction by two-window method standardizes cardiac I-123 MIBG uptake in various gamma camera systems. Ann Nucl Med 2003;17:309\u201313.","journal-title":"Ann Nucl Med"},{"key":"3146_CR39","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1212\/WNL.53.5.1020","volume":"53","author":"S Braune","year":"1999","unstructured":"Braune S, Reinhardt M, Schnitzer R, Riedel A, L\u00fccking CH. Cardiac uptake of [123I]MIBG separates Parkinson\u2019s disease from multiple system atrophy. Neurology 1999;53:1020\u20135.","journal-title":"Neurology"},{"key":"3146_CR40","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1007\/s00259-006-0155-x","volume":"33","author":"L Tossici-Bolt","year":"2006","unstructured":"Tossici-Bolt L, Hoffmann SM, Kemp PM, Mehta RL, Fleming JS. Quantification of [123I]FP-CIT SPECT brain images: an accurate technique for measurement of the specific binding ratio. Eur J Nucl Med Mol Imaging 2006;33:1491\u20139. doi: 10.1007\/s00259-006-0155-x .","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"Suppl 7","key":"3146_CR41","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1002\/mds.10576","volume":"18","author":"DC Costa","year":"2003","unstructured":"Costa DC, Walker Z, Walker RW, Fontes FR. Dementia with Lewy bodies versus Alzheimer\u2019s disease: role of dopamine transporter imaging. Mov Disord 2003;18 Suppl 7:S34\u20138. doi: 10.1002\/mds.10576 .","journal-title":"Mov Disord"},{"key":"3146_CR42","doi-asserted-by":"crossref","first-page":"6853","DOI":"10.1523\/JNEUROSCI.21-17-06853.2001","volume":"21","author":"E Bezard","year":"2001","unstructured":"Bezard E, Dovero S, Prunier C, Ravenscroft P, Chalon S, Guilloteau D, et al. Relationship between the appearance of symptoms and the level of nigrostriatal degeneration in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson\u2019s disease. J Neurosci 2001;21:6853\u201361.","journal-title":"J Neurosci"},{"key":"3146_CR43","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/1531-8257(200007)15:4<692::AID-MDS1014>3.0.CO;2-V","volume":"15","author":"HT Benamer","year":"2000","unstructured":"Benamer HT, Patterson J, Wyper DJ, Hadley DM, Macphee GJ, Grosset DG. Correlation of Parkinson\u2019s disease severity and duration with 123I-FP-CIT SPECT striatal uptake. Mov Disord 2000;15:692\u20138.","journal-title":"Mov Disord"},{"issue":"Suppl 7","key":"3146_CR44","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1002\/mds.10581","volume":"18","author":"PK Morrish","year":"2003","unstructured":"Morrish PK. How valid is dopamine transporter imaging as a surrogate marker in research trials in Parkinson\u2019s disease? Mov Disord 2003;18 Suppl 7:S63\u201370. doi: 10.1002\/mds.10581 .","journal-title":"Mov Disord"},{"key":"3146_CR45","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.2967\/jnumed.112.114025","volume":"54","author":"M Ziebell","year":"2013","unstructured":"Ziebell M, Andersen BB, Pinborg LH, Knudsen GM, Stokholm J, Thomsen G, et al. Striatal dopamine transporter binding does not correlate with clinical severity in dementia with Lewy bodies. J Nucl Med 2013;54:1072\u20136. doi: 10.2967\/jnumed.112.114025 .","journal-title":"J Nucl Med"},{"key":"3146_CR46","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s00259-011-1976-9","volume":"39","author":"M Ziebell","year":"2012","unstructured":"Ziebell M, Andersen BB, Thomsen G, Pinborg LH, Karlsborg M, Hasselbalch SG, et al. Predictive value of dopamine transporter SPECT imaging with [123I]PE2I in patients with subtle parkinsonian symptoms. Eur J Nucl Med Mol Imaging 2012;39:242\u201350. doi: 10.1007\/s00259-011-1976-9 .","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3146_CR47","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/ana.410410312","volume":"41","author":"Y Liu","year":"1997","unstructured":"Liu Y, Stern Y, Chun MR, Jacobs DM, Yau P, Goldman JE. Pathological correlates of extrapyramidal signs in Alzheimer\u2019s disease. Ann Neurol 1997;41:368\u201374. doi: 10.1002\/ana.410410312 .","journal-title":"Ann Neurol"},{"key":"3146_CR48","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1002\/ana.20635","volume":"58","author":"D Aarsland","year":"2005","unstructured":"Aarsland D, Perry R, Brown A, Larsen JP, Ballard C. Neuropathology of dementia in Parkinson\u2019s disease: a prospective, community-based study. Ann Neurol 2005;58:773\u20136. doi: 10.1002\/ana.20635 .","journal-title":"Ann Neurol"},{"key":"3146_CR49","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1212\/01.wnl.0000249130.63615.cc","volume":"67","author":"C Ballard","year":"2006","unstructured":"Ballard C, Ziabreva I, Perry R, Larsen JP, O\u2019Brien J, McKeith I, et al. Differences in neuropathologic characteristics across the Lewy body dementia spectrum. Neurology 2006;67:1931\u20134. doi: 10.1212\/01.wnl.0000249130.63615.cc .","journal-title":"Neurology"},{"key":"3146_CR50","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/2051-5960-1-65","volume":"1","author":"JB Toledo","year":"2013","unstructured":"Toledo JB, Cairns NJ, Da X, Chen K, Carter D, Fleisher A, et al. Clinical and multimodal biomarker correlates of ADNI neuropathological findings. Acta Neuropathol Commun 2013;1:65. doi: 10.1186\/2051-5960-1-65 .","journal-title":"Acta Neuropathol Commun"},{"key":"3146_CR51","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1253\/circj.CJ-08-0614","volume":"73","author":"K Sakata","year":"2009","unstructured":"Sakata K, Iida K, Mochizuki N, Ito M, Nakaya Y. Physiological changes in human cardiac sympathetic innervation and activity assessed by (123)I-metaiodobenzylguanidine (MIGB) imaging. Circ J 2009;73:310\u20135.","journal-title":"Circ J"},{"key":"3146_CR52","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1212\/01.wnl.0000249313.25627.2e","volume":"67","author":"T Miyamoto","year":"2006","unstructured":"Miyamoto T, Miyamoto M, Inoue Y, Usui Y, Suzuki K, Hirata K. Reduced cardiac 123I-MIBG scintigraphy in idiopathic REM sleep behavior disorder. Neurology 2006;67:2236\u20138. doi: 10.1212\/01.wnl.0000249313.25627.2e .","journal-title":"Neurology"},{"key":"3146_CR53","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/sleep\/31.5.717","volume":"31","author":"T Miyamoto","year":"2008","unstructured":"Miyamoto T, Miyamoto M, Suzuki K, Nishibayashi M, Iwanami M, Hirata K. 123I-MIBG cardiac scintigraphy provides clues to the underlying neurodegenerative disorder in idiopathic REM sleep behavior disorder. Sleep 2008;31:717\u201323.","journal-title":"Sleep"},{"key":"3146_CR54","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jns.2005.08.011","volume":"240","author":"M Suzuki","year":"2006","unstructured":"Suzuki M, Kurita A, Hashimoto M, Fukumitsu N, Abo M, Ito Y, et al. Impaired myocardial 123I-metaiodobenzylguanidine uptake in Lewy body disease: comparison between dementia with Lewy bodies and Parkinson\u2019s disease. J Neurol Sci 2006;240:15\u20139. doi: 10.1016\/j.jns.2005.08.011 .","journal-title":"J Neurol Sci"},{"key":"3146_CR55","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1212\/WNL.56.9.1143","volume":"56","author":"DS Knopman","year":"2001","unstructured":"Knopman DS, DeKosky ST, Cummings JL, Chui H, Corey-Bloom J, Relkin N, et al. Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001;56:1143\u201353.","journal-title":"Neurology"},{"key":"3146_CR56","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1212\/WNL.54.5.1050","volume":"54","author":"IG McKeith","year":"2000","unstructured":"McKeith IG, Ballard CG, Perry RH, Ince PG, O\u2019Brien JT, Neill D, et al. Prospective validation of consensus criteria for the diagnosis of dementia with Lewy bodies. Neurology 2000;54:1050\u20138.","journal-title":"Neurology"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-015-3146-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-015-3146-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-015-3146-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T00:07:31Z","timestamp":1567037251000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-015-3146-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,2]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["3146"],"URL":"https:\/\/doi.org\/10.1007\/s00259-015-3146-y","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,2]]}}}